Alpha-Hydroxy Carbonyl Reducing Agents at Mild pH
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
α-Hydroxy carbonyl compounds are not recognized as effective reducing agents at low alkalinity conditions, and existing methods require highly alkaline conditions or significant organic solvent use, limiting their application in reducing reactions.
Innovation Solution
Certain α-hydroxy carbonyl compounds, such as dihydroxyacetone, can act as reducing agents at relatively low pH values and in non-aqueous solvent systems, forming cyclic dimers and reducing organic or inorganic compounds, including transition metals, under mild conditions.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If α-hydroxy carbonyl compounds are used as reducing agents under conventional conditions, then reducing ability is achieved, but highly alkaline conditions (pH ≥ 11) are required
Solution Approach 1:
The invention changes the pH parameter from highly alkaline (pH ≥ 11) to mildly alkaline (pH 8-10.5) by using compounds of formula I, which possess inherent reducing ability at lower pH values. This is achieved through the specific molecular structure containing the α-hydroxy carbonyl group with particular substituents that enhance reducing capability while operating under milder conditions.
2Reliability
If conventional reducing agents are used, then reducing reactions can proceed, but significant quantities of concentrated alkali solutions are required
Solution Approach 1:
The invention uses compounds of formula I as disposable reducing agents that provide the necessary reducing capability without requiring large quantities of concentrated alkali solutions. The compounds themselves carry the reducing function, eliminating the need for excessive alkali as a separate reagent.
3Reliability
If α-hydroxy carbonyl compounds are used as reducing agents, then reducing effect is achieved, but pH values of over 13 are required
Solution Approach 1:
The invention changes the pH parameter from extremely alkaline (pH > 13) to mildly alkaline (pH 8-10.5) by employing compounds of formula I with specific substituent patterns. The structural features (R1, R2, aryl, Het groups) are designed to provide reducing ability under milder conditions, reducing the harmful effects of harsh alkalinity.
4Reliability
If conventional reduction methods are employed, then reduction of prodrugs can occur, but harsh conditions limit application versatility
Solution Approach 1:
The invention creates a universal reducing agent system (compounds of formula I) that can reduce various prodrugs and organic compounds under mild, compatible conditions. The mild alkaline pH and ability to function in diverse solvent systems make the method applicable to a wide range of substrates without requiring harsh conditions that would limit versatility.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach enables the use of α-hydroxy carbonyl compounds as effective reducing agents in a wider range of applications, including the reduction of prodrugs to active substances, without the need for harsh alkaline conditions or excessive organic solvents, enhancing reaction efficiency and versatility.
Implementation Method 1
Certain α-hydroxy carbonyl compounds, such as dihydroxyacetone, can act as reducing agents at relatively low pH values and in non-aqueous solvent systems, forming cyclic dimers and reducing organic or inorganic compounds, including transition metals, under mild conditions
Implementation Method 2
α-Hydroxy carbonyl compounds, although molecules that are capable of being oxidised, are not recognised to be useful as reducing agents under conditions of low alkalinity (pH
Data Source
AI summary
There is provided the use as reducing agents of alpha-hydroxycarbonyl compounds capable of forming cyclic dimers. There is also provided corresponding methods of reducing reducible compounds, particularly reduction-activated prodrugs. Examples of the alpha-hydroxycarbonyl compounds used are dihydroxyacetone, glycolaldehyde, glyceraldehyde, erythrose, xylulose, erythrulose or 3-hydroxy-2-butanone.